A nationwide population-based retrospective cohort study of the risk of uterine, ovarian and breast cancer inwomenwith polycystic ovary syndrome

Oncologist

Volumn 20, Issue 1, 2015, Pages 45-49

  Shen, Cheng Che ^a,b   Yang, Albert C ^c,d   Hung, Jeng Hsiu ^e,f   Hu, Li Yu ^d,g   Tsai, Shih Jen ^c,d  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL CHUNG CHENG UNIVERSITY   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

^e TAIPEI TZU CHI HOSPITAL   (Taiwan)

^f TZU CHI UNIVERSITY   (Taiwan)

^g KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Breast cancer; Ovarian cancer; Polycystic ovary syndrome; Retrospective cohort study; Uterine cancer

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CHILD; CHRONIC LUNG DISEASE; CLINICAL PROTOCOL; COHORT ANALYSIS; COMPARATIVE STUDY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; INFANT; MAJOR CLINICAL STUDY; MIDDLE AGED; MONTE CARLO METHOD; NEWBORN; OVARY CANCER; OVARY POLYCYSTIC DISEASE; POPULATION RESEARCH; PRIORITY JOURNAL; RETROSPECTIVE STUDY; UTERUS CANCER; BREAST NEOPLASMS; COMPLICATION; HEALTH SURVEY; OVARIAN NEOPLASMS; PATHOLOGY; POLYCYSTIC OVARY SYNDROME; RISK FACTOR; TAIWAN; UTERINE NEOPLASMS;

ADULT; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; POLYCYSTIC OVARY SYNDROME; POPULATION SURVEILLANCE; RETROSPECTIVE STUDIES; RISK FACTORS; TAIWAN; UTERINE NEOPLASMS;

EID: 84921295658     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2014-0311     Document Type: Article

References (26)

1. Asuncion M, Calvo RM, San Millan JL et al. A prospective studyof the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 2000;85: 2434–2438.
2. Cussons AJ, Stuckey BG, Watts GF. Cardiovascular disease in the polycystic ovary syndrome: New insights and perspectives. Atherosclerosis 2006; 185:227–239.
3. Orio F, Vuolo L, Palomba S et al. Metabolic and cardiovascular consequences of polycystic ovary syndrome. Minerva Ginecol 2008;60:39–51.
4. Jemal A, Siegel R, Xu J et al. Cancer statistics, 2010. CA Cancer J Clin 2010;60:277–300.
5. Speert H. Carcinomaoftheendometriuminyoung women. Surg Gynecol Obstet 1949;88:332–336.
6. Colafranceschi M, Taddei GL, Scarselli G et al. Clinico-pathological profile of endometrial carcinoma in young women (under 40 years of age). Eur J Gynaecol Oncol 1989;10:353–356.
7. Gadducci A, Gargini A, Palla E et al. Polycystic ovary syndrome and gynecological cancers: Is there a link? Gynecol Endocrinol 2005;20:200–208.
8. Gallup DG, Stock RJ. Adenocarcinoma of the endometrium in women 40 years of age or younger. Obstet Gynecol 1984;64:417–420.
9. Honore LH, Davey SJ. Endometrial carcinoma in young women: A report of four cases. J Reprod Med 1989;34:845–849.
10. Konishi I, Koshiyama M, Mandai M et al. Increased expression of LH/hCG receptors in endometrial hyperplasia and carcinoma in anovulatory women. Gynecol Oncol 1997;65:273–280.
11. Brinton LA, Moghissi KS, Westhoff CL et al. Cancer risk among infertile women with androgen excess or menstrual disorders (including polycystic ovary syndrome). Fertil Steril 2010;94:1787–1792.
12. Haoula Z, Salman M, Atiomo W. Evaluating the association between endometrial cancer and polycystic ovary syndrome. Hum Reprod 2012;27: 1327–1331.
13. Barry JA, Azizia MM, Hardiman PJ. Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: A systematic review and meta-analysis. Hum Reprod Update 2014;20:748–758.
14. Ou SM, Lee YJ, Hu YW et al. Does Alzheimer’s disease protect against cancers? A nationwide population-based study. Neuroepidemiology 2013; 40:42–49.
15. Wu CY, Chen YJ, Ho HJ et al. Associationbetween nucleoside analogues and risk of hepatitis B virusrelated hepatocellular carcinoma recurrence following liver resection. JAMA 2012;308:1906–1914.
16. Chen HL, Hsiao FY. Risk of hospitalization and healthcare cost associated with Diabetes Complication Severity Index in Taiwan’s National Health Insurance Research Database. J Diabetes Complications 2014;28:612–616.
17. Chen YC, Yeh HY, Wu JC et al. Taiwan’s National Health Insurance Research Database: Administrative health care database as study object in bibliometrics. Scientometrics 2011;86:365–380.
18. Introduction to the National Health Insurance Research Database (NHIRD). Taiwan. Available at http://nhird.nhri.org.tw/date_01.html. Accessed May 1, 2007.
19. Hardiman P, Pillay OC, Atiomo W. Polycystic ovary syndromeandendometrial carcinoma. Lancet 2003;361:1810–1812.
20. Sirmans SM, Pate KA. Epidemiology, diagnosis, andmanagement of polycystic ovary syndrome. Clin Epidemiol 2013;6:1–13.
21. Jick H, Walker AM, Rothman KJ. The epidemic of endometrial cancer: A commentary. Am J Public Health 1980;70:264–267.
22. Teede H, Deeks A, Moran L. Polycystic ovary syndrome: A complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med 2010;8:41.
23. Nevadunsky NS, Van Arsdale A, Strickler HD et al. Obesity and age at diagnosis of endometrial cancer. Obstet Gynecol 2014;124:300–306.
24. Semaan A, Ali-Fehmi R, Munkarah AR et al. Clinical/pathologic features and patient outcome in early onset endometrial carcinoma: A population based analysis and an institutional perspective from the Detroit metropolitan area, Michigan. Gynecol Oncol 2012;124:265–269.
25. Pierpoint T, McKeigue PM, Isaacs AJ et al. Mortality ofwomenwith polycystic ovary syndrome at long-term follow-up. J Clin Epidemiol 1998;51: 581–586.
26. Schildkraut JM, Schwingl PJ, Bastos E et al. Epithelial ovarian cancer risk among women with polycystic ovary syndrome. Obstet Gynecol 1996; 88:554–559.